PLAY PODCASTS
OncLive® On Air

OncLive® On Air

OncLive® On Air · Audioboom

609 episodesEN

Show overview

OncLive® On Air has been publishing since 2022, and across the 4 years since has built a catalogue of 609 episodes. That works out to roughly 180 hours of audio in total. Releases follow a several-times-a-week cadence, with the show now in its 16th season.

Episodes typically run ten to twenty minutes — most land between 11 min and 22 min — though episode length varies meaningfully from one episode to the next. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Health & Fitness show.

The show is actively publishing — the most recent episode landed 2 days ago, with 188 episodes already out so far this year. The busiest year was 2026, with 188 episodes published. Published by Audioboom.

Episodes
609
Running
2022–2026 · 4y
Median length
15 min
Cadence
Several per week

From the publisher

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

Latest Episodes

View all 609 episodes

S19 Ep5: Navigating Patient-Centric Treatment Administration Strategies in Myeloma

Oct 9, 20269 min

S19 Ep4: Novel MEK inhibitor Research Aims to Balance Efficacy and Tolerability in Pancreatic Cancer

Oct 7, 202610 min

S19 Ep3: FDA Approval Insights: Ropeginterferon Alfa-2b Ushers in Long-Awaited New Treatment Option for Essential Thrombocythemia

Oct 2, 202613 min

S19 Ep2: FDA Approval Insights: Daraxonrasib for Metastatic Pancreatic Ductal Adenocarcinoma

Sep 30, 202612 min

S19 Ep2: Resistance Patterns Shape FGFR Inhibitor Sequencing in Cholangiocarcinoma

Sep 30, 202616 min

S19 Ep1: Subcutaneous Therapies Bolster Administration Options in Multiple Myeloma

Sep 30, 202614 min

S18 Ep50: Navigating DLL3-Targeting T-Cell Engagers and the Evolving Small Cell Lung Cancer Treatment Landscape

Sep 30, 202617 min

S18 Ep49: Start Earlier and Find Your Community: Navigating the Fellowship-to-Faculty Transition Through Mentorship and Specialty-Focused Meetings

Sep 30, 202624 min

S18 Ep48: OncoBytes Adaptive Learning Pathways™: Decoding Precision Diagnostics and Targeted Therapies in Glioma

Sep 30, 202629 min

S18 Ep47: Dissecting Diagnostic and Management Factors in Systemic Mastocytosis

Sep 29, 202622 min

S18 Ep46: Unpacking Data and Upcoming Developments for Olverembatinib in CML

Sep 29, 202611 min

S18 Ep45: Advancing Targeted Therapy in HR+/HER2– Metastatic Breast Cancer: Integrating Next-Generation Endocrine and PAM-Pathway Strategies Into Practice

Sep 28, 202640 min

S18 Ep44: Exploring the FDA Approval of Optune Pax and What It Means for Locally Advanced Pancreatic Cancer

Sep 28, 202611 min

S18 Ep43: Neoadjuvant Immunotherapy and Short Treatment Courses Drive Paradigm Shifts in CRC Management

Sep 25, 202645 min

S18 Ep42: Breaking Down the FDA Approval of Zanidatamab-Based Regimens in HER2+ Gastric Cancer

Sep 24, 202611 min

S18 Ep41: Recent Data Readouts Help Untangle HER2 Overexpression and Mutation Implications in NSCLC

Sep 24, 202619 min

S18 Ep40: INCB161734 Holds Potential Significance for KRAS G12D–Mutated mPDAC Management

Sep 23, 202617 min

S18 Ep39: Pancreatic Cancer Experts Map Treatment Sequencing With Liposomal Irinotecan and Beyond

Sep 21, 202611 min

S18 Ep34: Integrating Precision Pathways in HER2+ Gastroesophageal Adenocarcinoma—Testing, Treatment, and Supportive Care

Sep 21, 202622 min

S18 Ep38: Fast-Moving Treatment Advances Shape B-Cell Lymphoma Care

Sep 17, 202624 min